SANGAMO THERAPEUTICS
Sangamo Therapeutics is a clinical-stage biotechnology company that translates ground-breaking science into genomic therapies transforming patients' lives using platform technologies in genome editing, gene therapy, gene regulation and cell therapy. The company's product pipeline includes Hemophilia, Central Nervous System, HIV, Lysosomal Storage Disorders, and Hemoglobinopathies.
SANGAMO THERAPEUTICS
Industry:
Biotechnology Genetics Health Care Pharmaceutical Therapeutics
Founded:
1995-01-01
Address:
Richmond, California, United States
Country:
United States
Website Url:
http://www.sangamo.com
Total Employee:
251+
Status:
Active
Contact:
5102368951
Email Addresses:
[email protected]
Total Funding:
522.1 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon Google Tag Manager WordPress Domain Not Resolving Wordpress Plugins Mobile Non Scaleable Content Nginx Sitelinks Search Box
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Agenus
Agenus develops and commercializes immunotherapies and vaccines for cancer and infectious diseases.
Altor BioScience
Altor BioScience researches and develops immunotherapeutic agents for the treatment of cancer, viral infections and autoimmune diseases.
Bluebird Bio
Bluebird Bio offers products based on the transformative potential of gene therapy for patients with genetic and orphan diseases.
Moderna Therapeutics
Moderna Therapeutics is a biotechnology company that specializes in drug discovery and drug development based on messenger RNA.
Translate Bio
Translate Bio is a biotechnology company that specializes in biotechnology, RNA therapeutics, and rare diseases.
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2018-07-23 | TxCell | TxCell acquired by Sangamo Therapeutics | 72 M EUR |
| 2013-08-26 | Ceregene | Ceregene acquired by Sangamo Therapeutics | N/A |
Investors List
California Institute for Regenerative Medicine
California Institute for Regenerative Medicine investment in Grant - Sangamo Therapeutics
National Institutes of Health
National Institutes of Health investment in Grant - Sangamo Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2020-04-17 | Sangamo Appoints D. Mark McClung as Executive Vice President and Chief Business Officer |
Official Site Inspections
http://www.sangamo.com Semrush global rank: 2.16 M Semrush visits lastest month: 9.21 K
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Sangamo Therapeutics"
Sangamo Therapeutics - Wikipedia
The company was founded in 1995 in Richmond, California. [3] It was originally known as Sangamo Biosciences, Inc. before changing names in 2017. In September 2018, it had 182 …See details»
Overview | Sangamo Therapeutics, Inc.
May 6, 2025 Sangamo is pioneering the future of genomic medicine. Sangamo Therapeutics is a genomic medicine company dedicated to translating groundbreaking science into medicines …See details»
Sangamo Therapeutics - Crunchbase Company Profile …
Organization. Sangamo Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ...See details»
Sangamo Therapeutics, Inc. Information - RocketReach
For Sangamo Therapeutics, science is a means to develop new medicines with the potential to transform the lives of patients living with serious genetic diseases. Our scientists are leaders in …See details»
Sangamo Therapeutics Company Profile - Craft
Oct 29, 2024 Sangamo Therapeutics (formerly known as Sangamo BioSciences) is a clinical-stage biopharmaceutical company focused on the research, development, and …See details»
Sangamo Therapeutics (SGMO) Company Profile & Description
Apr 6, 2000 Sangamo Therapeutics, Inc., a clinical-stage genomic medicine company, focuses on translating science into medicines that transform the lives of patients and families afflicted …See details»
Sangamo Therapeutics, Inc. (SGMO) - Yahoo Finance Canada
Sangamo Therapeutics, Inc., a clinical-stage genomic medicine company, focuses on translating science into medicines that transform the lives of patients and families afflicted with serious …See details»
Our Mission | Sangamo Therapeutics, Inc.
Sangamo is a genomic medicine company that seeks to help millions of people who suffer from severe diseases for which today’s medicine can only offer symptom management at best. Our mission is to translate ground-breaking …See details»
Environment | Social | Governance | Sangamo Therapeutics, Inc.
The Code helps Sangamo workers recognize and deal with ethical issues; provides mechanisms to report unethical conduct; and fosters a culture of honesty, integrity, and accountability. On …See details»
Corporate Profile: Sangamo BioSciences, Inc. - Taylor & Francis …
May 26, 2016 Sangamo BioSciences, Inc. (CA, USA) was founded in 1995 by current president and chief executive officer, E Lanphier, with the vision of developing a new paradigm in gene …See details»
Sangamo Therapeutics, Inc. (SGMO): history, ownership, mission, …
Ever wonder how a genomic medicine company like Sangamo Therapeutics, Inc. navigates the complex biotech landscape, especially after reporting research and development expenses of …See details»
Sangamo Programs On Genomic Medicine | Sangamo …
Sangamo’s novel technology and depth of scientific expertise make us a partner of choice among leading global pharmaceutical companies. Whether through in-licensing, out-licensing, …See details»
Overview | Sangamo Therapeutics, Inc.
Overview | Sangamo Therapeutics, Inc.See details»
Careers | Join Sangamo| Sangamo Therapeutics, Inc.
We believe Sangamo has a once-in-a-lifetime opportunity to transform the future of medicine. Join Sangamo and be a part of our team and grow with us. Sangamo Therapeutics to Present …See details»
Investors | Sangamo Therapeutics, Inc.
The Investor Relations website contains information about Sangamo Therapeutics, Inc.'s business for stockholders, potential investors, and financial analysts.See details»
Sangamo Therapeutics Announces Global Epigenetic Regulation …
Aug 6, 2024 Agreement leverages Sangamo’s proprietary capsid delivery platform and epigenetic regulation capabilities to address certain neurodegenerative diseases; Sangamo …See details»
Our Commitment to Serve Patients | Sangamo Therapeutics, Inc.
At Sangamo, we are committed to offering patients valuable information to support them along their journey. Explore our Patient Resources page for educational materials and a list of …See details»
Sangamo Announces Evolved Corporate Values, Reflecting Growth …
Our recently relaunched company values are reflective of Sangamo’s evolution as a leading genomic medicine company and our commitment to an inclusive and innovative internal …See details»
Earnings call transcript: Sangamo Therapeutics faces stock drop …
4 days ago Sangamo Therapeutics reported its Q1 2025 earnings with a significant aftermarket stock price drop of 42.35%, closing at $0.4305. The company, currently valued at $168.64 …See details»
Sangamo Therapeutics, Inc. (SGMO) Q1 2025 Earnings Call Transcript
3 days ago Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q1 2025 Earnings Conference Call May 12, 2025 6:30 PM ET. Company Participants. Louise Wilkie - Vice President, Investor …See details»